What caused the recent spike in Hikal Limited's trading volume?

The volume spike in Hikal Limited's stock is attributed to recent market volatility and increased investor interest, resulting in a 9.19% price increase.

How does Hikal Limited compare to its industry peers?

Compared to peers like Glenmark Pharmaceuticals, Hikal has shown greater price volatility but a comparable market cap, reflecting broader industry challenges.

What are the technical indicators suggesting for Hikal's stock?

Technical indicators such as RSI and MACD point towards a bearish trend, suggesting caution for short-term investors amid market fluctuations, as assessed by Meyka AI.

What is Hikal Limited's future price target consensus?

Analysts anticipate that Hikal's stock price could reach INR 250.58 in the short term and up to INR 404.27 in three years, assuming improvement in fundamentals.

What is the current analyst rating for Hikal Limited?

Hikal Limited has a 'B' grade with a 'Hold' recommendation, reflecting potential benefits from strategic initiatives and market recovery trends, albeit with increasing risks.

IN Stocks

Hikal Limited (HIKAL.NS) Sees Volume Spike Amid Market Volatility: What to Expect Next?

ByHuzaifa Zahoor December 4, 2025December 4, 2025

Hikal Limited (HIKAL.NS) recently experienced a significant volume spike on the NSE, with trading volume soaring to 44,504,833—remarkably higher than its average volume of 247,635. This movement pushed its stock price to INR 244.17, marking a 9.19% change. Let’s delve into the factors fueling this spike and what it means for investors.